Impact ledger
Jaguar Health, Inc. (JAGX)
5 events mapped to this ticker since 2026-06-22.
Assumption changes
| Date | Assumption | Direction | Magnitude | Conf. |
|---|---|---|---|---|
| 2026-06-25 | working_capital | Bearish | — | 0.70 |
| 2026-06-22 | share_count | Bullish | — | 0.70 |
| 2026-06-22 | net_debt | Bullish | — | 0.70 |
| 2026-06-22 | revenue | Bullish | — | 0.70 |
| 2026-06-22 | multiple | Bullish | — | 0.70 |
| 2026-06-19 | net_debt | Bearish | — | 0.70 |
| 2026-06-19 | interest_expense | Bearish | — | 0.70 |
Event impact log
| Date | Event | Channel | Direction | Horizon | Impact |
|---|---|---|---|---|---|
| 2026-06-25 | Event | Direct disclosure of a material definitive agreement, which could be an acquisition, divestiture, significant partnership, or financing event. | watch | 1-5d | 0.80 |
| 2026-06-25 | Event | Dilution from conversion of preferred stock into common stock, increasing the share count. | Bearish | intraday | 0.70 |
| 2026-06-22 | Event | Regulatory disclosure of potentially material non-public information. The specific content of the 8-K is unknown without further detail, but Regulation FD filings often precede or accompany significant corporate events. | watch | 1-5d | 0.60 |
| 2026-06-22 | Event | Uncertainty regarding the outcome of strategic review; potential for no deal or a dilutive transaction. | watch | 3-12m | 0.60 |
| 2026-06-22 | Event | Potential acquisition premium or partnership deal for its rare disease drug candidate, crofelemer. | Bullish | 1-3m | 0.80 |
This ledger is regenerated from Market Ontology's public event pipeline. For live alerts on new assumption changes for JAGX, start a trial or view the JAGX entity page.